Healthgen Biotechnology

Exhibitor

Healthgen Biotechnology Corp. (Healthgen Biotech), specializing in molecular pharmaceutical research and development, is focusing on developing and manufacturing a series of animal-free and safety products by using the state-of-the Art platform called OryzHiExp, having high capacity to express proteins or small peptides in the rice grain.
Utilizing the rice endosperm cell specific expression platform, Healthgen Biotech have achievements in developing and commercializing a series of products, including recombinant human serum albumin (OsrHSA), recombinant human basic fibroblast growth factor (OsrbFGF), recombinant alphar-1 antitrypsin (OsrAAT), recombinant human epidermal growth factor (OsrEGF), recombinant human basic fibroblast growth factor (OsrbFGF), recombinant human Fibronectin (OsrFn), recombinant human lactoferrin (OsrLF), and recombinant lysozyme (OsrLYZ). Meanwhile, based on the OryzHiExp expression platform, Healthgen Biotech can provide customized protein or peptides expression services.
The recombinant human serum albumin (OsrHSA) has gained the DMF from US FDA, which number is 029648. The OsrHSA can be used as excipient and stabilizer in a variety of pharmaceutical preparations and serum-free cell culture medium component.
Healthgen Biotech’s Quality Control System has been certified by ISO 9001: 2008 and ensures standardized process as well as qualified produc

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.

TO SPONSOR / EXHIBIT

Erica Baeta 
+44 (0)207 092 1152 
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson 
t/ +44 (0)207 092 1150 
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor 
+44 (0)207 092 1257 
issa.mauthoor@terrapinn.com